↓ Skip to main content

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients…

Overview of attention for article published in BMC Cancer, August 2017
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Published in
BMC Cancer, August 2017
DOI 10.1186/s12885-017-3526-8
Pubmed ID
Authors

Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye, Per Pfeiffer, - on behalf of the Academy of Geriatric Cancer Research (AgeCare)

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 16%
Student > Bachelor 8 10%
Researcher 7 9%
Student > Ph. D. Student 7 9%
Other 6 8%
Other 18 23%
Unknown 19 25%
Readers by discipline Count As %
Medicine and Dentistry 32 42%
Biochemistry, Genetics and Molecular Biology 6 8%
Unspecified 4 5%
Nursing and Health Professions 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 8 10%
Unknown 20 26%